VICTORIA THOMAS: Open Payments
NPI 1124412770 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 41 payments from 15 companies in 2025. Trend: 2023 $1,281 · 2024 $1,482 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $173 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $122 |
| ABBVIE INC. | 4 | $118 |
| PFIZER INC. | 5 | $111 |
| Novo Nordisk Inc | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: Korlym, ISTURISA, NURTEC ODT, QULIPTA, FARXIGA, Ozempic, Wegovy, JARDIANCE.
Industry payments across TX — which companies pay providers there.
